+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Ursodeoxycholic Acid Market 2023-2027

  • PDF Icon

    Report

  • 152 Pages
  • August 2023
  • Region: Global
  • TechNavio
  • ID: 5876726
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The ursodeoxycholic acid market is forecasted to grow by USD 358.41 mn during 2022-2027, accelerating at a CAGR of 10.65% during the forecast period. The report on the ursodeoxycholic acid market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in number of liver transplants, increasing incidence of primary sclerosing cholangitis and associated diseases, and expansion of indications for UDCA.

The ursodeoxycholic acid market is segmented as below:

By Type

  • Synthetic ursodeoxycholic acid
  • Extraction ursodeoxycholic acid

By Application

  • Pharmacy products
  • Health products

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing demand for combination therapies as one of the prime reasons driving the ursodeoxycholic acid market growth during the next few years. Also, increasing focus on emerging economies and technological advancements in drug delivery systems will lead to sizable demand in the market.

The report on the ursodeoxycholic acid market covers the following areas:

  • Ursodeoxycholic acid market sizing
  • Ursodeoxycholic acid market forecast
  • Ursodeoxycholic acid market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ursodeoxycholic acid market vendors that include Abil Chempharma Pvt. Ltd., Anant Pharmaceuticals Pvt. Ltd., Changde Yungang Biotechnology Co. Ltd., Daewoong Bio Inc., Dipharma Francis S.r.l., Glenmark Pharmaceuticals Ltd., ICE S.p.a., JSC Grindeks, Kimia Biosciences Ltd., Merck KGaA, Mitsubishi Chemical Group Corp., Osmopharm SA, Panjin Hengchanglong Pharmaceutical Co. Ltd., Suzhou Tianlu Bio Pharmaceutical Co. Ltd., Tianjin NWS Biotechnology and Medicine Co. Ltd., Travere Therapeutics Inc., Zhongshan Belling Biotechnology Co. Ltd., Axplora, Cerata Pharmaceuticals LLP, and Octavius Pharma Pvt. Ltd. Also, the ursodeoxycholic acid market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global ursodeoxycholic acid market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global ursodeoxycholic acid market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Synthetic ursodeoxycholic acid - Market size and forecast 2022-2027
Exhibit 34: Chart on Synthetic ursodeoxycholic acid - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Synthetic ursodeoxycholic acid - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Synthetic ursodeoxycholic acid - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Synthetic ursodeoxycholic acid - Year-over-year growth 2022-2027 (%)
6.4 Extraction ursodeoxycholic acid - Market size and forecast 2022-2027
Exhibit 38: Chart on Extraction ursodeoxycholic acid - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Extraction ursodeoxycholic acid - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Extraction ursodeoxycholic acid - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Extraction ursodeoxycholic acid - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022-2027 (%)
Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Pharmacy products - Market size and forecast 2022-2027
Exhibit 48: Chart on Pharmacy products - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Pharmacy products - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Pharmacy products - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Pharmacy products - Year-over-year growth 2022-2027 (%)
7.4 Health products - Market size and forecast 2022-2027
Exhibit 52: Chart on Health products - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Health products - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Health products - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Health products - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Application
Exhibit 56: Market opportunity by Application ($ million)
Exhibit 57: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share by geography 2022-2027 (%)
Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 95: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 99: Market opportunity by geography ($ million)
Exhibit 100: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abil Chempharma Pvt. Ltd.
Exhibit 107: Abil Chempharma Pvt. Ltd. - Overview
Exhibit 108: Abil Chempharma Pvt. Ltd. - Product/Service
Exhibit 109: Abil Chempharma Pvt. Ltd. - Key offerings
12.4 Anant Pharmaceuticals Pvt. Ltd.
Exhibit 110: Anant Pharmaceuticals Pvt. Ltd. - Overview
Exhibit 111: Anant Pharmaceuticals Pvt. Ltd. - Product/Service
Exhibit 112: Anant Pharmaceuticals Pvt. Ltd. - Key offerings
12.5 Axplora
Exhibit 113: Axplora - Overview
Exhibit 114: Axplora - Product/Service
Exhibit 115: Axplora - Key offerings
12.6 Changde Yungang Biotechnology Co. Ltd.
Exhibit 116: Changde Yungang Biotechnology Co. Ltd. - Overview
Exhibit 117: Changde Yungang Biotechnology Co. Ltd. - Product/Service
Exhibit 118: Changde Yungang Biotechnology Co. Ltd. - Key offerings
12.7 Daewoong Bio Inc.
Exhibit 119: Daewoong Bio Inc. - Overview
Exhibit 120: Daewoong Bio Inc. - Product/Service
Exhibit 121: Daewoong Bio Inc. - Key offerings
12.8 Dipharma Francis S.r.l.
Exhibit 122: Dipharma Francis S.r.l. - Overview
Exhibit 123: Dipharma Francis S.r.l. - Product/Service
Exhibit 124: Dipharma Francis S.r.l. - Key offerings
12.9 Glenmark Pharmaceuticals Ltd.
Exhibit 125: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 126: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibit 127: Glenmark Pharmaceuticals Ltd. - Key offerings
12.10 ICE S.p.a.
Exhibit 128: ICE S.p.a. - Overview
Exhibit 129: ICE S.p.a. - Product/Service
Exhibit 130: ICE S.p.a. - Key offerings
12.11 JSC Grindeks
Exhibit 131: JSC Grindeks - Overview
Exhibit 132: JSC Grindeks - Product/Service
Exhibit 133: JSC Grindeks - Key offerings
12.12 Merck KGaA
Exhibit 134: Merck KGaA - Overview
Exhibit 135: Merck KGaA - Business segments
Exhibit 136: Merck KGaA - Key news
Exhibit 137: Merck KGaA - Key offerings
Exhibit 138: Merck KGaA - Segment focus
12.13 Mitsubishi Chemical Group Corp.
Exhibit 139: Mitsubishi Chemical Group Corp. - Overview
Exhibit 140: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 141: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 142: Mitsubishi Chemical Group Corp. - Segment focus
12.14 Panjin Hengchanglong Pharmaceutical Co. Ltd.
Exhibit 143: Panjin Hengchanglong Pharmaceutical Co. Ltd. - Overview
Exhibit 144: Panjin Hengchanglong Pharmaceutical Co. Ltd. - Product/Service
Exhibit 145: Panjin Hengchanglong Pharmaceutical Co. Ltd. - Key offerings
12.15 Suzhou Tianlu Bio Pharmaceutical Co. Ltd.
Exhibit 146: Suzhou Tianlu Bio Pharmaceutical Co. Ltd. - Overview
Exhibit 147: Suzhou Tianlu Bio Pharmaceutical Co. Ltd. - Product/Service
Exhibit 148: Suzhou Tianlu Bio Pharmaceutical Co. Ltd. - Key offerings
12.16 Tianjin NWS Biotechnology and Medicine Co. Ltd.
Exhibit 149: Tianjin NWS Biotechnology and Medicine Co. Ltd. - Overview
Exhibit 150: Tianjin NWS Biotechnology and Medicine Co. Ltd. - Product/Service
Exhibit 151: Tianjin NWS Biotechnology and Medicine Co. Ltd. - Key offerings
12.17 Travere Therapeutics Inc.
Exhibit 152: Travere Therapeutics Inc. - Overview
Exhibit 153: Travere Therapeutics Inc. - Product/Service
Exhibit 154: Travere Therapeutics Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 155: Inclusions checklist
Exhibit 156: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 157: Currency conversion rates for US$
13.4 Research methodology
Exhibit 158: Research methodology
Exhibit 159: Validation techniques employed for market sizing
Exhibit 160: Information sources
13.5 List of abbreviations
Exhibit 161: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global ursodeoxycholic acid market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Synthetic ursodeoxycholic acid - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Synthetic ursodeoxycholic acid - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Synthetic ursodeoxycholic acid - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Synthetic ursodeoxycholic acid - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Extraction ursodeoxycholic acid - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Extraction ursodeoxycholic acid - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Extraction ursodeoxycholic acid - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Extraction ursodeoxycholic acid - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Chart on Application - Market share 2022-2027 (%)
Exhibits 45: Data Table on Application - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Application
Exhibits 47: Data Table on Comparison by Application
Exhibits 48: Chart on Pharmacy products - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Pharmacy products - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Pharmacy products - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Pharmacy products - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Health products - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Health products - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Health products - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Health products - Year-over-year growth 2022-2027 (%)
Exhibits 56: Market opportunity by Application ($ million)
Exhibits 57: Data Table on Market opportunity by Application ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share by geography 2022-2027 (%)
Exhibits 60: Data Table on Market share by geography 2022-2027 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 99: Market opportunity by geography ($ million)
Exhibits 100: Data Tables on Market opportunity by geography ($ million)
Exhibits 101: Impact of drivers and challenges in 2022 and 2027
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Abil Chempharma Pvt. Ltd. - Overview
Exhibits 108: Abil Chempharma Pvt. Ltd. - Product/Service
Exhibits 109: Abil Chempharma Pvt. Ltd. - Key offerings
Exhibits 110: Anant Pharmaceuticals Pvt. Ltd. - Overview
Exhibits 111: Anant Pharmaceuticals Pvt. Ltd. - Product/Service
Exhibits 112: Anant Pharmaceuticals Pvt. Ltd. - Key offerings
Exhibits 113: Axplora - Overview
Exhibits 114: Axplora - Product/Service
Exhibits 115: Axplora - Key offerings
Exhibits 116: Changde Yungang Biotechnology Co. Ltd. - Overview
Exhibits 117: Changde Yungang Biotechnology Co. Ltd. - Product/Service
Exhibits 118: Changde Yungang Biotechnology Co. Ltd. - Key offerings
Exhibits 119: Daewoong Bio Inc. - Overview
Exhibits 120: Daewoong Bio Inc. - Product/Service
Exhibits 121: Daewoong Bio Inc. - Key offerings
Exhibits 122: Dipharma Francis S.r.l. - Overview
Exhibits 123: Dipharma Francis S.r.l. - Product/Service
Exhibits 124: Dipharma Francis S.r.l. - Key offerings
Exhibits 125: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 126: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibits 127: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 128: ICE S.p.a. - Overview
Exhibits 129: ICE S.p.a. - Product/Service
Exhibits 130: ICE S.p.a. - Key offerings
Exhibits 131: JSC Grindeks - Overview
Exhibits 132: JSC Grindeks - Product/Service
Exhibits 133: JSC Grindeks - Key offerings
Exhibits 134: Merck KGaA - Overview
Exhibits 135: Merck KGaA - Business segments
Exhibits 136: Merck KGaA - Key news
Exhibits 137: Merck KGaA - Key offerings
Exhibits 138: Merck KGaA - Segment focus
Exhibits 139: Mitsubishi Chemical Group Corp. - Overview
Exhibits 140: Mitsubishi Chemical Group Corp. - Business segments
Exhibits 141: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits 142: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits 143: Panjin Hengchanglong Pharmaceutical Co. Ltd. - Overview
Exhibits 144: Panjin Hengchanglong Pharmaceutical Co. Ltd. - Product/Service
Exhibits 145: Panjin Hengchanglong Pharmaceutical Co. Ltd. - Key offerings
Exhibits 146: Suzhou Tianlu Bio Pharmaceutical Co. Ltd. - Overview
Exhibits 147: Suzhou Tianlu Bio Pharmaceutical Co. Ltd. - Product/Service
Exhibits 148: Suzhou Tianlu Bio Pharmaceutical Co. Ltd. - Key offerings
Exhibits 149: Tianjin NWS Biotechnology and Medicine Co. Ltd. - Overview
Exhibits 150: Tianjin NWS Biotechnology and Medicine Co. Ltd. - Product/Service
Exhibits 151: Tianjin NWS Biotechnology and Medicine Co. Ltd. - Key offerings
Exhibits 152: Travere Therapeutics Inc. - Overview
Exhibits 153: Travere Therapeutics Inc. - Product/Service
Exhibits 154: Travere Therapeutics Inc. - Key offerings
Exhibits 155: Inclusions checklist
Exhibits 156: Exclusions checklist
Exhibits 157: Currency conversion rates for US$
Exhibits 158: Research methodology
Exhibits 159: Validation techniques employed for market sizing
Exhibits 160: Information sources
Exhibits 161: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global ursodeoxycholic acid market: Abil Chempharma Pvt. Ltd., Anant Pharmaceuticals Pvt. Ltd., Changde Yungang Biotechnology Co. Ltd., Daewoong Bio Inc., Dipharma Francis S.r.l., Glenmark Pharmaceuticals Ltd., ICE S.p.a., JSC Grindeks, Kimia Biosciences Ltd., Merck KGaA, Mitsubishi Chemical Group Corp., Osmopharm SA, Panjin Hengchanglong Pharmaceutical Co. Ltd., Suzhou Tianlu Bio Pharmaceutical Co. Ltd., Tianjin NWS Biotechnology and Medicine Co. Ltd., Travere Therapeutics Inc., Zhongshan Belling Biotechnology Co. Ltd., Axplora, Cerata Pharmaceuticals LLP, and Octavius Pharma Pvt. Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing demand for combination therapies.'

According to the report, one of the major drivers for this market is the rise in number of liver transplants.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abil Chempharma Pvt. Ltd.
  • Anant Pharmaceuticals Pvt. Ltd.
  • Changde Yungang Biotechnology Co. Ltd.
  • Daewoong Bio Inc.
  • Dipharma Francis S.r.l.
  • Glenmark Pharmaceuticals Ltd.
  • ICE S.p.a.
  • JSC Grindeks
  • Kimia Biosciences Ltd.
  • Merck KGaA
  • Mitsubishi Chemical Group Corp.
  • Osmopharm SA
  • Panjin Hengchanglong Pharmaceutical Co. Ltd.
  • Suzhou Tianlu Bio Pharmaceutical Co. Ltd.
  • Tianjin NWS Biotechnology and Medicine Co. Ltd.
  • Travere Therapeutics Inc.
  • Zhongshan Belling Biotechnology Co. Ltd.
  • Axplora
  • Cerata Pharmaceuticals LLP
  • Octavius Pharma Pvt. Ltd.

Related Topics

Related Reports

Ursodeoxycholic Acid Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Ursodeoxycholic Acid Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 94 Pages
  • Global
From
Ursodeoxycholic Acid Drug Product Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Ursodeoxycholic Acid Drug Product Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From
Ursodeoxycholic acid (CAS 128-13-2) Global Market Research Report 2024 - Product Image

Ursodeoxycholic acid (CAS 128-13-2) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Gastrointestinal Diseases Therapeutics Market 2023-2027 - Product Image

Global Gastrointestinal Diseases Therapeutics Market 2023-2027

  • Report
  • 168 Pages
  • Global
From
Global Antiemetic Drug Market 2023-2027 - Product Image

Global Antiemetic Drug Market 2023-2027

  • Report
  • 179 Pages
  • Global
From

About the Ursodeoxycholic Acid Market

Ursodeoxycholic Acid (UDCA) is a bile acid used in the treatment of gastrointestinal diseases. It is used to treat primary biliary cirrhosis, a chronic liver disease, and to dissolve gallstones. UDCA is also used to treat other conditions such as primary sclerosing cholangitis, biliary atresia, and cholestatic liver diseases. It is available in oral and intravenous forms. UDCA is a naturally occurring bile acid found in the small intestine and is used to reduce the amount of cholesterol in bile. It is also used to reduce the risk of gallstone formation and to reduce the symptoms of gallbladder disease. The UDCA market is a part of the larger gastrointestinal drugs market. It is a growing market, driven by the increasing prevalence of gastrointestinal diseases and the increasing demand for effective treatments. The market is expected to grow due to the increasing awareness of the benefits of UDCA and the increasing availability of generic versions of the drug. Some of the major companies in the UDCA market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.